SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062822-21-000042
Filing Date
2021-07-30
Accepted
2021-07-30 07:52:00
Documents
12
Period of Report
2021-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20210730.htm   iXBRL 8-K 34246
  Complete submission text file 0001062822-21-000042.txt   180385

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20210730.xsd EX-101.SCH 1917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20210730_lab.xml EX-101.LAB 23970
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20210730_pre.xml EX-101.PRE 12648
6 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20210730_htm.xml XML 11891
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 211130077
SIC: 2834 Pharmaceutical Preparations